What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (2 Viewers)

Capella said:
I truly hope this isn’t the case 
Click to expand...
In a sense yes but it’s also an exaggeration.  I have my retirement and long portfolio that neither are in.  But I do have an account that I started with the intent of learning the stock game and eventually options. This is money I’m prepared to lose and look at it like Vegas gambling money.  This account currently is all CYDY and GME.  My 1500 shares of CYDY are free rolling at this point, GME is at 252 average and getting crushed.  

 
  • Sad
Reactions: KGB
The next leg down will happen when people come to the realization that there is no conditional EUA coming.  Cytodyn is going to have finish these next trials before anything happens.  We are at least six months out at this point  and on top of that HIV is not close either.  There will be more competitors approved before they get anything.

I really think there will be an opportunity to invest in this under $1.50 within a couple of months at most.

 
Dwayne Hoover said:
The next leg down will happen when people come to the realization that there is no conditional EUA coming.  Cytodyn is going to have finish these next trials before anything happens.  We are at least six months out at this point  and on top of that HIV is not close either.  There will be more competitors approved before they get anything.

I really think there will be an opportunity to invest in this under $1.50 within a couple of months at most.
Click to expand...
By no means is an EUA off the table.  With credible management, I think they'd be a strong favorite to get it.  With Nader and Kelly, 50% IMO.  An EUA is a very safe way for the FDA to save face and dip its toe in the lake of CYDY.

 
Dwayne Hoover said:
The next leg down will happen when people come to the realization that there is no conditional EUA coming.  Cytodyn is going to have finish these next trials before anything happens.  We are at least six months out at this point  and on top of that HIV is not close either.  There will be more competitors approved before they get anything.

I really think there will be an opportunity to invest in this under $1.50 within a couple of months at most.
Click to expand...
I am not 100% sure that they even applied for one.  No press release mentioning it.  And in his last CC he mentioned that he applied for a conditional EUA or something to that effect.  I believe he sent a pre-submittal or a request for information regarding an EUA.  I find it hard to believe that they wouldn't have been loud and proud in announcing an EUA application on their website.

No one trusts NP at all.  

 
Chaz McNulty said:
I am not 100% sure that they even applied for one.  No press release mentioning it.  And in his last CC he mentioned that he applied for a conditional EUA or something to that effect.  I believe he sent a pre-submittal or a request for information regarding an EUA.  I find it hard to believe that they wouldn't have been loud and proud in announcing an EUA application on their website.

No one trusts NP at all.  
Click to expand...
I believe they did apply because FDA employees are now prohibited from trading CYDY and that change happened in March.  I will also direct you to this page at the FDA's website where they describe why an EUA might have some conditions attached to it.

 
chet said:
I believe they did apply because FDA employees are now prohibited from trading CYDY and that change happened in March.  I will also direct you to this page at the FDA's website where they describe why an EUA might have some conditions attached to it.
Click to expand...
Thanks.  That's the first time I've seen literature on the conditional part.  I really hope you're right and they did submit one.  I am just cautious on this because he seemed to indicate that he submitted one in the CD10 trial and it came out 3 weeks later that he didn't.

 
Chaz McNulty said:
Thanks.  That's the first time I've seen literature on the conditional part.  I really hope you're right and they did submit one.  I am just cautious on this because he seemed to indicate that he submitted one in the CD10 trial and it came out 3 weeks later that he didn't.
Click to expand...
He flat out lied. No way to flip it.

 
chet said:
IC FBGCav said:
Now if only the test results were very good, we might have some momentum.   
Click to expand...
Come now, GB.  Results were ok and should be good enough to get an EUA.
Click to expand...
Re the bolded- I think the compelling missing piece that makes the bolded true is LL’s safety record.  The results + how safe it is should be good enough to get an EUA. 

 
Last edited by a moderator:
chet said:
Come now, GB.  Results were ok and should be good enough to get an EUA.
Click to expand...
I really don't think it's good enough for an EUA.  They found a tiny population where it showed a good result and the FDA is not going to go out of there way to work with them.

Back at the drawing board and the problem I have right now is since I can't trust NP at all, I have no idea what drawing board they are seriously on.

is the HIV BLA ever going to be done? No idea. Not confident that it is under this management.

Are they going to try and fill more trials for Covid?  Can they afford it?

The Nash and cancer is way too far out to be taken seriously.

 
Hgen let’s goooooooooooo

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced positive topline results from its Phase 3 clinical trial evaluating the efficacy and safety of lenzilumab in patients hospitalized with COVID-19. Trial results showed that patients who received lenzilumab and other treatments, including steroids and/or remdesivir, had a 54% greater relative likelihood of survival without the need for IMV compared with patients receiving placebo and other treatments. These results are statistically significant.

 
Capella said:
Hgen let’s goooooooooooo

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced positive topline results from its Phase 3 clinical trial evaluating the efficacy and safety of lenzilumab in patients hospitalized with COVID-19. Trial results showed that patients who received lenzilumab and other treatments, including steroids and/or remdesivir, had a 54% greater relative likelihood of survival without the need for IMV compared with patients receiving placebo and other treatments. These results are statistically significant.
Click to expand...
Might be a great opportunity to sell. I recall they had price targets on HGEN of $25 back when it was in the single digits. Key difference now is that there was no vaccine news at that point versus the rollout already underway.

By the time they have meaningful revenue and report it, I’d imagine the real results will be way lower than those estimates pre-vaccines.

 
Last edited by a moderator:
stbugs said:
Might be a great opportunity to sell. I recall they had price targets on HGEN of $25 back when it was in the single digits. Key difference now is that there was no vaccine news at that point versus the rollout already underway.
Click to expand...
Wouldn’t sell now with a gun to my head lol. I’m in this for a rocket or nothing. 
 

...but I do agree the chance of mega returns is significantly diminished. 

 
Last edited by a moderator:
Capella said:
Hgen let’s goooooooooooo

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced positive topline results from its Phase 3 clinical trial evaluating the efficacy and safety of lenzilumab in patients hospitalized with COVID-19. Trial results showed that patients who received lenzilumab and other treatments, including steroids and/or remdesivir, had a 54% greater relative likelihood of survival without the need for IMV compared with patients receiving placebo and other treatments. These results are statistically significant.
Click to expand...
Only 21.50 premarket?  Should we be buying?  This is disappointing if the pop

 
Dwayne Hoover said:
Okay wise guy, not sure if you know this but most analysts had this in the 30s.  Its fine to be disappointed if the pop.
Click to expand...
I don’t know what you’re talking about, the market isn’t open yet and I’m excited — I’m sorry you’re still carrying a grudge about cydy. 

 
Capella said:
Hgen let’s goooooooooooo

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced positive topline results from its Phase 3 clinical trial evaluating the efficacy and safety of lenzilumab in patients hospitalized with COVID-19. Trial results showed that patients who received lenzilumab and other treatments, including steroids and/or remdesivir, had a 54% greater relative likelihood of survival without the need for IMV compared with patients receiving placebo and other treatments. These results are statistically significant.
Click to expand...
Great news.  How long do you think until they get approved?

 
Capella said:
Wouldn’t sell now with a gun to my head lol. I’m in this for a rocket or nothing. 
 

...but I do agree the chance of mega returns is significantly diminished. 
Click to expand...
Maybe true, just saying that I do recall the rosy analyst projections had the stock at $25 when it was floating just under $10, before vaccine news. That could be a reason why the pop is fading a bit. Kind of like GameStop, I have a feeling each time the real results come out, it’ll have been better to sell before. You’ve probably got a while till then but I think vaccine numbers are going to keep going up.

Just one man’s opinion. 

 
stbugs said:
Maybe true, just saying that I do recall the rosy analyst projections had the stock at $25 when it was floating just under $10, before vaccine news. That could be a reason why the pop is fading a bit. Kind of like GameStop, I have a feeling each time the real results come out, it’ll have been better to sell before. You’ve probably got a while till then but I think vaccine numbers are going to keep going up.

Just one man’s opinion. 
Click to expand...
I dunno man the market isn’t even open for 20 minutes and it’s up 66%. I don’t know what some people are expecting. 

 
You must log in or register to reply here.

Similar threads

wadegarrett
***Official OHIO STATE-MICHIGAN Thread***
40 41 42
Replies
2K
Views
53K
Blue Dot Orange Dot
B
Bob Magaw
*** Official 2011 St. Louis Rams Thread ***
Replies
21
Views
2K
Bob Magaw
Bob Magaw
Couch Potato
Couch Potato 2012 Dynasty Rankings
4 5 6
Replies
293
Views
40K
Spin
Spin

Users who are viewing this thread

Total: 1 (members: 0, guests: 1)
Back
Top